Log In Sign up
The largest database of trusted experimental protocols

Snrnp40 sab2701506 and srsf2 sc35 clone sc 35

Manufactured by Merck Group
Visit Supplier

SNRNP40 (SAB2701506) is a laboratory reagent used for research purposes. It is a recombinant protein that can be used for applications such as immunoprecipitation and Western blotting. SRSF2/SC35 (clone SC-35) is an antibody that can be used to detect the SRSF2 protein, which is involved in RNA splicing. This antibody can be used for techniques like immunofluorescence and immunohistochemistry.

Automatically generated - may contain errors

Lab products found in correlation

Dna modifying enzymes, by Roche (2 mentions) Ku55933, by R&D Systems (2 mentions) Nu7441, by R&D Systems (2 mentions) Rnaseh2a nbp1 76981, by Novus Biologicals (2 mentions) Snrpa u1a 3f9 1f7, by Abcepta (2 mentions) Gfp 11 814 460 001, by Roche (2 mentions) Phospho chk2 thr68 2661, by Cell Signaling Technology (2 mentions) Odyssey compatible irdye680 and irdye800 conjugated secondary antibodies, by LI COR (2 mentions) Mnase, by Merck Group (2 mentions) Gfp trap beads, by Proteintech (2 mentions) Pladienolide b, by Santa Cruz Biotechnology (2 mentions) β tubulin, by Santa Cruz Biotechnology (2 mentions) Cpd tdm 2, by MBL Life Science (2 mentions)

Spelling variants of this product

SC-35 (6 citations)

2 protocols using snrnp40 sab2701506 and srsf2 sc35 clone sc 35

1

Comprehensive Chromatin Immunoprecipitation and Protein Interaction Mapping

Check if the same lab product or an alternative is used in the 5 most similar protocols
MNase and all chemicals were purchased from Sigma-Aldrich unless otherwise specified. DNA modifying enzymes were from Roche Applied Sciences. Pladienolide B was from Santa Cruz Biotechnology, the ATR inhibitor VE821 from TINIB-Tools, and the ATM inhibitor KU55933 and DNA-PK inhibitor NU7441 from R&D Systems. Antibodies used were against: PRP8 (H300), XPA/p62 (FL-273), p89/XPB (S-19) and β-Tubulin from Santa Cruz Biotechnology; SNRPC/U1C (NBP1-96048), NHP2L1 (NBP1-32732), SF3a1 (NB100-79847), SF3b2 (NV100-79843), RNaseH1 (NBP2-20171), and RNaseH2A (NBP1-76981) from Novus Biologicals; SNRNP40 (SAB2701506) and SRSF2/SC35 (clone SC-35) from Sigma; SNRPA/U1A (3F9-1F7) from ABGENT; PRPF3 (ab187535), RNPII CTD (phospho-S2) (ab5095), RNAPII (ab5095), PCNA (PC-10), Ki67 (ab833) from abcam®; CPD (TDM-2) from MBL International; GFP (11 814 460 001) from Roche; H2A (07-146) from Millipore Corp.; phosphor-ATM(1981)(05-740) from Upstate Biotechnology, Phospho-CHK2(Thr68) (2661) from Cell Signaling. Anti-XPC (rabbit-polyclonal ab) was in-house developed. Odyssey-compatible IRDye680- and IRDye800–conjugated secondary antibodies were from LI-COR. Secondary antibodies conjugated to Alexa Fluorochromes-488, -568, -594 and-647 were from Invitrogen. GFP-tagged proteins were immunoprecipitated with GFP-Trap® beads (ChromoTek).
Tresini M., Warmerdam D.O., Kolovos P., Snijder L., Vrouwe M.G., Demmers J.A., van IJcken W.F., Grosveld F.G., Medema R.H., Hoeijmakers J.H., Mullenders L.H., Vermeulen W, & Marteijn J.A. (2015). The core spliceosome as target and effector of non-canonical ATM signaling. Nature, 523(7558), 53-58.
+ Open protocol
+ Expand
2

Comprehensive Chromatin Immunoprecipitation and Protein Interaction Mapping

Check if the same lab product or an alternative is used in the 5 most similar protocols
MNase and all chemicals were purchased from Sigma-Aldrich unless otherwise specified. DNA modifying enzymes were from Roche Applied Sciences. Pladienolide B was from Santa Cruz Biotechnology, the ATR inhibitor VE821 from TINIB-Tools, and the ATM inhibitor KU55933 and DNA-PK inhibitor NU7441 from R&D Systems. Antibodies used were against: PRP8 (H300), XPA/p62 (FL-273), p89/XPB (S-19) and β-Tubulin from Santa Cruz Biotechnology; SNRPC/U1C (NBP1-96048), NHP2L1 (NBP1-32732), SF3a1 (NB100-79847), SF3b2 (NV100-79843), RNaseH1 (NBP2-20171), and RNaseH2A (NBP1-76981) from Novus Biologicals; SNRNP40 (SAB2701506) and SRSF2/SC35 (clone SC-35) from Sigma; SNRPA/U1A (3F9-1F7) from ABGENT; PRPF3 (ab187535), RNPII CTD (phospho-S2) (ab5095), RNAPII (ab5095), PCNA (PC-10), Ki67 (ab833) from abcam®; CPD (TDM-2) from MBL International; GFP (11 814 460 001) from Roche; H2A (07-146) from Millipore Corp.; phosphor-ATM(1981)(05-740) from Upstate Biotechnology, Phospho-CHK2(Thr68) (2661) from Cell Signaling. Anti-XPC (rabbit-polyclonal ab) was in-house developed. Odyssey-compatible IRDye680- and IRDye800–conjugated secondary antibodies were from LI-COR. Secondary antibodies conjugated to Alexa Fluorochromes-488, -568, -594 and-647 were from Invitrogen. GFP-tagged proteins were immunoprecipitated with GFP-Trap® beads (ChromoTek).
Tresini M., Warmerdam D.O., Kolovos P., Snijder L., Vrouwe M.G., Demmers J.A., van IJcken W.F., Grosveld F.G., Medema R.H., Hoeijmakers J.H., Mullenders L.H., Vermeulen W, & Marteijn J.A. (2015). The core spliceosome as target and effector of non-canonical ATM signaling. Nature, 523(7558), 53-58.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!